Literature DB >> 29507395

Pan-cancer analysis of somatic mutations across 21 neuroendocrine tumor types.

Yanan Cao1,2, Weiwei Zhou3, Lin Li3, Jiaqian Wang4, Zhibo Gao4, Yiran Jiang3, Xiuli Jiang3, Aijing Shan3, Matthew H Bailey5,6, Kuan-Lin Huang5,6, Sam Q Sun5,6, Michael D McLellan5, Beifang Niu5,7, Weiqing Wang3, Li Ding8,9,10, Guang Ning11,12.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29507395      PMCID: PMC5951840          DOI: 10.1038/s41422-018-0019-5

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  10 in total

1.  DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.

Authors:  Yuchen Jiao; Chanjuan Shi; Barish H Edil; Roeland F de Wilde; David S Klimstra; Anirban Maitra; Richard D Schulick; Laura H Tang; Christopher L Wolfgang; Michael A Choti; Victor E Velculescu; Luis A Diaz; Bert Vogelstein; Kenneth W Kinzler; Ralph H Hruban; Nickolas Papadopoulos
Journal:  Science       Date:  2011-01-20       Impact factor: 47.728

2.  Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1.

Authors:  Yanan Cao; Zhibo Gao; Lin Li; Xiuli Jiang; Aijing Shan; Jie Cai; Ying Peng; Yanli Li; Xiaohua Jiang; Xuanlin Huang; Jiaqian Wang; Qing Wei; Guijun Qin; Jiajun Zhao; Xiaolong Jin; Li Liu; Yingrui Li; Weiqing Wang; Jun Wang; Guang Ning
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 3.  Carcinoid and neuroendocrine tumors: building on success.

Authors:  Pamela L Kunz
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

4.  ARRDC3 suppresses breast cancer progression by negatively regulating integrin beta4.

Authors:  K M Draheim; H-B Chen; Q Tao; N Moore; M Roche; S Lyle
Journal:  Oncogene       Date:  2010-07-05       Impact factor: 9.867

5.  Transposon mutagenesis identifies genes and evolutionary forces driving gastrointestinal tract tumor progression.

Authors:  Haruna Takeda; Zhubo Wei; Hideto Koso; Alistair G Rust; Christopher Chin Kuan Yew; Michael B Mann; Jerrold M Ward; David J Adams; Neal G Copeland; Nancy A Jenkins
Journal:  Nat Genet       Date:  2015-01-05       Impact factor: 38.330

6.  Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids.

Authors:  Lynnette Fernandez-Cuesta; Martin Peifer; Xin Lu; Ruping Sun; Luka Ozretić; Danila Seidal; Thomas Zander; Frauke Leenders; Julie George; Christian Müller; Ilona Dahmen; Berit Pinther; Graziella Bosco; Kathryn Konrad; Janine Altmüller; Peter Nürnberg; Viktor Achter; Ulrich Lang; Peter M Schneider; Magdalena Bogus; Alex Soltermann; Odd Terje Brustugun; Åslaug Helland; Steinar Solberg; Marius Lund-Iversen; Sascha Ansén; Erich Stoelben; Gavin M Wright; Prudence Russell; Zoe Wainer; Benjamin Solomon; John K Field; Russell Hyde; Michael Pa Davies; Lukas C Heukamp; Iver Petersen; Sven Perner; Christine Lovly; Federico Cappuzzo; William D Travis; Jürgen Wolf; Martin Vingron; Elisabeth Brambilla; Stefan A Haas; Reinhard Buettner; Roman K Thomas
Journal:  Nat Commun       Date:  2014-03-27       Impact factor: 14.919

7.  Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma.

Authors:  Mark Sausen; Rebecca J Leary; Siân Jones; Jian Wu; C Patrick Reynolds; Xueyuan Liu; Amanda Blackford; Giovanni Parmigiani; Luis A Diaz; Nickolas Papadopoulos; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu; Michael D Hogarty
Journal:  Nat Genet       Date:  2012-12-02       Impact factor: 38.330

8.  The genetic landscape of high-risk neuroblastoma.

Authors:  Trevor J Pugh; Olena Morozova; Edward F Attiyeh; Shahab Asgharzadeh; Jun S Wei; Daniel Auclair; Scott L Carter; Kristian Cibulskis; Megan Hanna; Adam Kiezun; Jaegil Kim; Michael S Lawrence; Lee Lichenstein; Aaron McKenna; Chandra Sekhar Pedamallu; Alex H Ramos; Erica Shefler; Andrey Sivachenko; Carrie Sougnez; Chip Stewart; Adrian Ally; Inanc Birol; Readman Chiu; Richard D Corbett; Martin Hirst; Shaun D Jackman; Baljit Kamoh; Alireza Hadj Khodabakshi; Martin Krzywinski; Allan Lo; Richard A Moore; Karen L Mungall; Jenny Qian; Angela Tam; Nina Thiessen; Yongjun Zhao; Kristina A Cole; Maura Diamond; Sharon J Diskin; Yael P Mosse; Andrew C Wood; Lingyun Ji; Richard Sposto; Thomas Badgett; Wendy B London; Yvonne Moyer; Julie M Gastier-Foster; Malcolm A Smith; Jaime M Guidry Auvil; Daniela S Gerhard; Michael D Hogarty; Steven J M Jones; Eric S Lander; Stacey B Gabriel; Gad Getz; Robert C Seeger; Javed Khan; Marco A Marra; Matthew Meyerson; John M Maris
Journal:  Nat Genet       Date:  2013-01-20       Impact factor: 38.330

9.  Mutational landscape and significance across 12 major cancer types.

Authors:  Cyriac Kandoth; Michael D McLellan; Fabio Vandin; Kai Ye; Beifang Niu; Charles Lu; Mingchao Xie; Qunyuan Zhang; Joshua F McMichael; Matthew A Wyczalkowski; Mark D M Leiserson; Christopher A Miller; John S Welch; Matthew J Walter; Michael C Wendl; Timothy J Ley; Richard K Wilson; Benjamin J Raphael; Li Ding
Journal:  Nature       Date:  2013-10-17       Impact factor: 49.962

10.  Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway.

Authors:  I H Lee; M Sohn; H J Lim; S Yoon; H Oh; S Shin; J H Shin; S-H Oh; J Kim; D K Lee; D Y Noh; D S Bae; J K Seong; Y S Bae
Journal:  Oncogene       Date:  2014-03-24       Impact factor: 9.867

  10 in total
  1 in total

1.  hPG80 (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors.

Authors:  Aman Chauhan; Alexandre Prieur; Jill Kolesar; Susanne Arnold; Léa Payen; Younes Mahi; Berengere Vire; Madison Sands; B Mark Evers; Dominique Joubert; Lowell Anthony
Journal:  Cancers (Basel)       Date:  2022-02-09       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.